A limited sampling strategy to estimate the pharmacokinetic parameters of irinotecan and its active metabolite, SN-38, in patients with metastatic digestive cancer receiving the FOLFIRI regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples